By AuntMinnieEurope.com staff writers

October 7, 2019 -- Computer-aided detection (CAD) and radiation therapy firm iCAD plans to highlight its ProFound AI platform for artificial intelligence (AI) at the upcoming French national radiology congress (JFR) in Paris.

ProFound AI comes in a digital breast tomosynthesis (DBT) version, which received the CE Mark in March 2018. In addition, ProFound AI for DBT was cleared by the U.S. Food and Drug Administration (FDA) in December 2018, iCAD said.

The company also offers ProFound AI for 2D mammography, which received the CE Mark in July 2019.


Copyright © 2019 AuntMinnieEurope.com
 

To read this and get access to all of the exclusive content on AuntMinnieEurope.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnieEurope.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: